Showing 148,621 - 148,640 results of 226,199 for search '(( 5 ((step decrease) OR (mean decrease)) ) OR ( 10 ((nn decrease) OR (a decrease)) ))', query time: 1.75s Refine Results
  1. 148621

    ΔTgPPM3C parasites exhibit growth defects <i>in vitro</i> and <i>in vivo</i>. by Joshua Mayoral (9922544)

    Published 2020
    “…Plaque size was quantified in ImageJ, using the Kruskal-Wallis and Dunn’s multiple comparisons test to compare each group and generate p values. A significant decrease in plaque size is observed in the ΔTgPPM3C strain compared to TgPPM3C-HA and TgPPM3C-COMP strains. …”
  2. 148622

    Table1_Neuroprotective potency of mangiferin against 3-nitropropionic acid induced Huntington’s disease-like symptoms in rats: possible antioxidant and anti-inflammatory mechanisms... by Pei Teng Lum (16537509)

    Published 2023
    “…Further, a significant depletion in brain malondialdehyde (MDA) level, an increase in reduced glutathione (GSH) level, succinate dehydrogenase (SDH), superoxide dismutase (SOD) and catalase (CAT) activities, and a decrease in tumor necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β) and interleukin-6 (IL-6) levels were observed in mangiferin treated groups. …”
  3. 148623

    Marketed vaccines against canine leishmaniasis. by Llum Páez (22553360)

    Published 2025
    “…The primary safety endpoint was the absence of serious local and/or systemic adverse events and/or deaths attributable to vaccination. Neoleish demonstrated a high safety profile. No signs of shock, local or systemic reactions were observed even after the administration of an overdose (10x) of Neoleish followed by a repeated dose. …”
  4. 148624
  5. 148625
  6. 148626

    Table 1_Variations in vitamin D status among Chinese children aged 1–6 years during the COVID-19 pandemic.xlsx by Yongfeng Qiao (3354326)

    Published 2025
    “…Additionally, the concentrations of 25(OH)D in spring exhibited a decrease during the COVID-19 pandemic (37.9 ± 10.3 ng/ml) in comparison to the pre-pandemic measurements (39.3 ± 9.9 ng/ml) (p = 0.008), while winter concentrations increased from (35.1 ± 10.4 ng/ml) to (37.9 ± 10.3 ng/ml) during the pandemic (p = 0.002).…”
  7. 148627
  8. 148628

    Fig 6 - by Thomas S. Kraft (3255267)

    Published 2023
    “…All scenarios are depicted relative to baseline (black), with red-blue colors depicting degree of increase–decrease in target parameter. The data underlying this Figure can be found in <a href="http://10.0.68.197/OSF.IO/7YB2M" target="_blank">http://doi.org/10.17605/OSF.IO/7YB2M</a> (files: <a href="https://osf.io/9qgpr" target="_blank">https://osf.io/9qgpr</a>, <a href="https://osf.io/57bm8" target="_blank">https://osf.io/57bm8</a>, <a href="https://osf.io/gp8sn" target="_blank">https://osf.io/gp8sn</a>, <a href="https://osf.io/tewp4" target="_blank">https://osf.io/tewp4</a>, <a href="https://osf.io/p8aqr" target="_blank">https://osf.io/p8aqr</a>, <a href="https://osf.io/4xdhc" target="_blank">https://osf.io/4xdhc</a>, <a href="https://osf.io/vp562" target="_blank">https://osf.io/vp562</a>, <a href="https://osf.io/42kxf" target="_blank">https://osf.io/42kxf</a>, <a href="https://osf.io/anfhz" target="_blank">https://osf.io/anfhz</a>, <a href="https://osf.io/hav6t" target="_blank">https://osf.io/hav6t</a>, <a href="https://osf.io/xjubn" target="_blank">https://osf.io/xjubn</a>, <a href="https://osf.io/h5fxe" target="_blank">https://osf.io/h5fxe</a>, <a href="https://osf.io/f798u" target="_blank">https://osf.io/f798u</a>, <a href="https://osf.io/a5cvm" target="_blank">https://osf.io/a5cvm</a>, <a href="https://osf.io/ykt52" target="_blank">https://osf.io/ykt52</a>, <a href="https://osf.io/cer5h" target="_blank">https://osf.io/cer5h</a>).…”
  9. 148629

    Loss of <i>Fgf3</i> causes variable anterior-posterior axis truncation and caudal malformation. by Matthew J. Anderson (265883)

    Published 2016
    “…An apparent dynamic domain of <i>Fgf3</i> is observed in the anterior PSM (<b>asterisks</b>) (see <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1006018#pgen.1006018.s001" target="_blank">S1 Fig</a>). …”
  10. 148630

    Exosin inhibits ExoS ADPRT activity. by Anthony Arnoldo (42511)

    Published 2008
    “…(D) Plot of the slope from (c) (K<sub>M</sub>/V<sub>max</sub>) against E216-5303 concentration (see <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1000005#s4" target="_blank">Material and Methods</a> for details). …”
  11. 148631

    The Influence of Hepatitis B Viral Load and Pre-S Deletion Mutations on Post-Operative Recurrence of Hepatocellular Carcinoma and the Tertiary Preventive Effects by Anti-Viral Ther... by Chien-Wei Su (383483)

    Published 2013
    “…</p><p>Results</p><p>After a median follow-up of 45.9 months, 208 patients had HCC recurrence after resection. …”
  12. 148632

    NOS network and reporters expression for cell lines grown 2i conditions. by Elsa Abranches (261932)

    Published 2013
    “…This change is accompanied by a decrease in the expression levels of <i>Fgf5</i> and <i>Dusp6</i> when FGF/ERK signaling is abolished (**p-value <5.8×10<sup>−6</sup>). …”
  13. 148633

    Data from: Colour patch size and measurement error using reflectance spectrometry by Arnaud Badiane (3768376)

    Published 2022
    “…<h3>Usage Notes</h3> Spectra_3mmSpectra obtained at a 3-mm distance of the different centre/surround colour combinations of the artificial coloured plastic plates used in Experiment 1.Data_3mm.xlsxSpectra_5mmSpectra obtained at a 5-mm distance of the different colour combinations of the artificial coloured plastic sheets used in experiment 1.Data_5mm.xlsxPmuralis_spectra_OVSSpectra of the UV outer-ventral scale (OVS) displayed by Podarcis muralis, spectra of their orange ventral coloration, and spectra of their black coloration. …”
  14. 148634

    The sequence between nt. 626/640 mediates both TPA-dependent activation and the negative regulation by T3/TR. by Hiroko Misawa (335240)

    Published 2013
    “…The stimulatory effect by TPA is decreased in MA. In the presence or absence of TPA (100 ng/ml), pBL-FFL-CAT5 (WT) or its mutants (MA-D) were transfected into CV1 cells. …”
  15. 148635

    Hog1-dependent Spt4 phosphorylation is required for stress-dependent RNA levels. by Andrea Silva (4418386)

    Published 2017
    “…<p><b>(A)</b> The Spt4<sup>T42AS43A</sup> mutant showed a decrease in <i>CTT1</i> mRNA expression versus wild type (wt) when induced by the LexA-Vp16 activator. …”
  16. 148636

    Table_4_Effects of circulating inflammatory proteins on osteoporosis and fractures: evidence from genetic correlation and Mendelian randomization study.xlsx by Qingcong Zheng (11169094)

    Published 2024
    “…</p>Results<p>The IVW results with Bonferroni correction indicated that CXCL11 (OR = 1.2049; 95% CI: 1.0308-1.4083; P = 0.0192) can increase the risk of OP; IL-4 (OR = 1.2877; 95% CI: 1.1003-1.5070; P = 0.0016), IL-7 (OR = 1.2572; 95% CI: 1.0401-1.5196; P = 0.0180), IL-15RA (OR = 1.1346; 95% CI: 1.0163-1.2668; P = 0.0246), IL-17C (OR = 1.1353; 95% CI: 1.0272-1.2547; P = 0.0129), CXCL10 (OR = 1.2479; 95% CI: 1.0832-1.4377; P = 0.0022), eotaxin/CCL11 (OR = 1.1552; 95% CI: 1.0525-1.2678; P = 0.0024), and FGF23 (OR = 1.9437; 95% CI: 1.1875-3.1816; P = 0.0082) can increase the risk of fractures; whereas IL-10RB (OR = 0.9006; 95% CI: 0.8335-0.9730; P = 0.0080), CCL4 (OR = 0.9101; 95% CI: 0.8385-0.9878; P = 0.0242), MCP-3/CCL7 (OR = 0.8579; 95% CI: 0.7506-0.9806; P = 0.0246), IFN-γ [shoulder and upper arm (OR = 0.7832; 95% CI: 0.6605-0.9287; P = 0.0049); rib(s), sternum and thoracic spine (OR = 0.7228; 95% CI: 0.5681-0.9197; P = 0.0083)], β-NGF (OR = 0.8384; 95% CI: 0.7473-0.9407; P = 0.0027), and SIRT2 (OR = 0.5167; 95% CI: 0.3296-0.8100; P = 0.0040) can decrease fractures risk.…”
  17. 148637

    DataSheet_1_Effects of circulating inflammatory proteins on osteoporosis and fractures: evidence from genetic correlation and Mendelian randomization study.pdf by Qingcong Zheng (11169094)

    Published 2024
    “…</p>Results<p>The IVW results with Bonferroni correction indicated that CXCL11 (OR = 1.2049; 95% CI: 1.0308-1.4083; P = 0.0192) can increase the risk of OP; IL-4 (OR = 1.2877; 95% CI: 1.1003-1.5070; P = 0.0016), IL-7 (OR = 1.2572; 95% CI: 1.0401-1.5196; P = 0.0180), IL-15RA (OR = 1.1346; 95% CI: 1.0163-1.2668; P = 0.0246), IL-17C (OR = 1.1353; 95% CI: 1.0272-1.2547; P = 0.0129), CXCL10 (OR = 1.2479; 95% CI: 1.0832-1.4377; P = 0.0022), eotaxin/CCL11 (OR = 1.1552; 95% CI: 1.0525-1.2678; P = 0.0024), and FGF23 (OR = 1.9437; 95% CI: 1.1875-3.1816; P = 0.0082) can increase the risk of fractures; whereas IL-10RB (OR = 0.9006; 95% CI: 0.8335-0.9730; P = 0.0080), CCL4 (OR = 0.9101; 95% CI: 0.8385-0.9878; P = 0.0242), MCP-3/CCL7 (OR = 0.8579; 95% CI: 0.7506-0.9806; P = 0.0246), IFN-γ [shoulder and upper arm (OR = 0.7832; 95% CI: 0.6605-0.9287; P = 0.0049); rib(s), sternum and thoracic spine (OR = 0.7228; 95% CI: 0.5681-0.9197; P = 0.0083)], β-NGF (OR = 0.8384; 95% CI: 0.7473-0.9407; P = 0.0027), and SIRT2 (OR = 0.5167; 95% CI: 0.3296-0.8100; P = 0.0040) can decrease fractures risk.…”
  18. 148638

    Table_2_Effects of circulating inflammatory proteins on osteoporosis and fractures: evidence from genetic correlation and Mendelian randomization study.xlsx by Qingcong Zheng (11169094)

    Published 2024
    “…</p>Results<p>The IVW results with Bonferroni correction indicated that CXCL11 (OR = 1.2049; 95% CI: 1.0308-1.4083; P = 0.0192) can increase the risk of OP; IL-4 (OR = 1.2877; 95% CI: 1.1003-1.5070; P = 0.0016), IL-7 (OR = 1.2572; 95% CI: 1.0401-1.5196; P = 0.0180), IL-15RA (OR = 1.1346; 95% CI: 1.0163-1.2668; P = 0.0246), IL-17C (OR = 1.1353; 95% CI: 1.0272-1.2547; P = 0.0129), CXCL10 (OR = 1.2479; 95% CI: 1.0832-1.4377; P = 0.0022), eotaxin/CCL11 (OR = 1.1552; 95% CI: 1.0525-1.2678; P = 0.0024), and FGF23 (OR = 1.9437; 95% CI: 1.1875-3.1816; P = 0.0082) can increase the risk of fractures; whereas IL-10RB (OR = 0.9006; 95% CI: 0.8335-0.9730; P = 0.0080), CCL4 (OR = 0.9101; 95% CI: 0.8385-0.9878; P = 0.0242), MCP-3/CCL7 (OR = 0.8579; 95% CI: 0.7506-0.9806; P = 0.0246), IFN-γ [shoulder and upper arm (OR = 0.7832; 95% CI: 0.6605-0.9287; P = 0.0049); rib(s), sternum and thoracic spine (OR = 0.7228; 95% CI: 0.5681-0.9197; P = 0.0083)], β-NGF (OR = 0.8384; 95% CI: 0.7473-0.9407; P = 0.0027), and SIRT2 (OR = 0.5167; 95% CI: 0.3296-0.8100; P = 0.0040) can decrease fractures risk.…”
  19. 148639

    Table_1_Effects of circulating inflammatory proteins on osteoporosis and fractures: evidence from genetic correlation and Mendelian randomization study.xlsx by Qingcong Zheng (11169094)

    Published 2024
    “…</p>Results<p>The IVW results with Bonferroni correction indicated that CXCL11 (OR = 1.2049; 95% CI: 1.0308-1.4083; P = 0.0192) can increase the risk of OP; IL-4 (OR = 1.2877; 95% CI: 1.1003-1.5070; P = 0.0016), IL-7 (OR = 1.2572; 95% CI: 1.0401-1.5196; P = 0.0180), IL-15RA (OR = 1.1346; 95% CI: 1.0163-1.2668; P = 0.0246), IL-17C (OR = 1.1353; 95% CI: 1.0272-1.2547; P = 0.0129), CXCL10 (OR = 1.2479; 95% CI: 1.0832-1.4377; P = 0.0022), eotaxin/CCL11 (OR = 1.1552; 95% CI: 1.0525-1.2678; P = 0.0024), and FGF23 (OR = 1.9437; 95% CI: 1.1875-3.1816; P = 0.0082) can increase the risk of fractures; whereas IL-10RB (OR = 0.9006; 95% CI: 0.8335-0.9730; P = 0.0080), CCL4 (OR = 0.9101; 95% CI: 0.8385-0.9878; P = 0.0242), MCP-3/CCL7 (OR = 0.8579; 95% CI: 0.7506-0.9806; P = 0.0246), IFN-γ [shoulder and upper arm (OR = 0.7832; 95% CI: 0.6605-0.9287; P = 0.0049); rib(s), sternum and thoracic spine (OR = 0.7228; 95% CI: 0.5681-0.9197; P = 0.0083)], β-NGF (OR = 0.8384; 95% CI: 0.7473-0.9407; P = 0.0027), and SIRT2 (OR = 0.5167; 95% CI: 0.3296-0.8100; P = 0.0040) can decrease fractures risk.…”
  20. 148640

    Table_3_Effects of circulating inflammatory proteins on osteoporosis and fractures: evidence from genetic correlation and Mendelian randomization study.xlsx by Qingcong Zheng (11169094)

    Published 2024
    “…</p>Results<p>The IVW results with Bonferroni correction indicated that CXCL11 (OR = 1.2049; 95% CI: 1.0308-1.4083; P = 0.0192) can increase the risk of OP; IL-4 (OR = 1.2877; 95% CI: 1.1003-1.5070; P = 0.0016), IL-7 (OR = 1.2572; 95% CI: 1.0401-1.5196; P = 0.0180), IL-15RA (OR = 1.1346; 95% CI: 1.0163-1.2668; P = 0.0246), IL-17C (OR = 1.1353; 95% CI: 1.0272-1.2547; P = 0.0129), CXCL10 (OR = 1.2479; 95% CI: 1.0832-1.4377; P = 0.0022), eotaxin/CCL11 (OR = 1.1552; 95% CI: 1.0525-1.2678; P = 0.0024), and FGF23 (OR = 1.9437; 95% CI: 1.1875-3.1816; P = 0.0082) can increase the risk of fractures; whereas IL-10RB (OR = 0.9006; 95% CI: 0.8335-0.9730; P = 0.0080), CCL4 (OR = 0.9101; 95% CI: 0.8385-0.9878; P = 0.0242), MCP-3/CCL7 (OR = 0.8579; 95% CI: 0.7506-0.9806; P = 0.0246), IFN-γ [shoulder and upper arm (OR = 0.7832; 95% CI: 0.6605-0.9287; P = 0.0049); rib(s), sternum and thoracic spine (OR = 0.7228; 95% CI: 0.5681-0.9197; P = 0.0083)], β-NGF (OR = 0.8384; 95% CI: 0.7473-0.9407; P = 0.0027), and SIRT2 (OR = 0.5167; 95% CI: 0.3296-0.8100; P = 0.0040) can decrease fractures risk.…”